Evidence map›Paper›PMID 29549279›Full record

ArticleScientific reports2018

Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission.

Ángel Agis-Torres, Paz Recio, María Elvira López-Oliva, María Pilar Martínez, María Victoria Barahona, Sara Benedito, Salvador Bustamante, Miguel Ángel Jiménez-Cidre, Albino García-Sacristán, Dolores Prieto and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ángel Agis-TorresDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Paz RecioDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
María Elvira López-OlivaDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
María Pilar MartínezDepartamento de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040, Madrid, Spain.
María Victoria BarahonaDepartamento de Toxicología y Farmacología, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Sara BeneditoDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Salvador BustamanteServicio de Urología, Hospital Universitario Puerta de Hierro-Majadahonda, 28222, Madrid, Spain.
Miguel Ángel Jiménez-CidreServicio de Urología, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain.
Albino García-SacristánDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Dolores PrietoDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Vítor S FernandesDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain.
Medardo HernándezDepartamento de Fisiología, Facultad de Farmacia, Universidad Complutense de Madrid, 28040, Madrid, Spain. medardo@ucm.es.
Universidad Complutense de Madrid · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Ramón y Cajal · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) and hydrogen sulfide (H

Indexed as

AdultAgedAnimalsCyclic Nucleotide Phosphodiesterases, Type 4HumansHydrogen SulfideMaleMiddle AgedMuscle RelaxationMuscle, SmoothNitric OxidePhosphodiesterase 4 InhibitorsRolipramSwineSynaptic TransmissionUrinary BladderCyclic Nucleotide Phosphodiesterases, Type 4Hydrogen SulfideNitric OxidePhosphodiesterase 4 InhibitorsRolipram

Identifiers

PMID29549279
PMCPMC5856743
OpenAlexW2805582198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.